173 related articles for article (PubMed ID: 6819104)
1. Application of stable labelled drugs in clinical pharmacokinetic investigations.
Eichelbaum M; von Unruh GE; Somogyi A
Clin Pharmacokinet; 1982; 7(6):490-507. PubMed ID: 6819104
[No Abstract] [Full Text] [Related]
2. Pharmacokinetic drug interactions.
Eichelbaum M
J Clin Pharmacol; 1986; 26(6):469-73. PubMed ID: 3090111
[TBL] [Abstract][Full Text] [Related]
3. Albumin-binding interactions of sodium valproate.
Fleitman JS; Bruni J; Perrin JH; Wilder BJ
J Clin Pharmacol; 1980; 20(8-9):514-7. PubMed ID: 6776162
[TBL] [Abstract][Full Text] [Related]
4. Prediction of the disposition of nine weakly acidic and six weakly basic drugs in humans from pharmacokinetic parameters in rats.
Sawada Y; Hanano M; Sugiyama Y; Iga T
J Pharmacokinet Biopharm; 1985 Oct; 13(5):477-92. PubMed ID: 3938813
[TBL] [Abstract][Full Text] [Related]
5. New method that gives true least squares fit of one and two compartment open pharmacokinetic models applied to valproic acid and methadone.
Lawyer CH; Gerber N
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):253-68. PubMed ID: 6777838
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics in liver cirrhosis].
Ackermann E
Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
[TBL] [Abstract][Full Text] [Related]
7. Effect of disease states on plasma protein binding of drugs.
Reidenberg MM
Med Clin North Am; 1974 Sep; 58(5):1103-9. PubMed ID: 4607741
[No Abstract] [Full Text] [Related]
8. Drug interactions.
Nies AS
Med Clin North Am; 1974 Sep; 58(5):965-75. PubMed ID: 4607406
[No Abstract] [Full Text] [Related]
9. Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies.
Perucca E
Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():71-8. PubMed ID: 6423336
[TBL] [Abstract][Full Text] [Related]
10. Drug displacement from protein-binding and redistributional interactions.
McQueen EG
Prog Biochem Pharmacol; 1974; 9():122-8. PubMed ID: 4140531
[No Abstract] [Full Text] [Related]
11. Clinical pharmacokinetics of sodium valproate, carbamazepine and phenytoin. Level-dose ration and interactions.
Levy RH; Moreland TA
Schweiz Rundsch Med Prax; 1984 Feb; 73(6):159-63. PubMed ID: 6424205
[No Abstract] [Full Text] [Related]
12. Comparative pharmacokinetics of coumarin anticoagulants XLV: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin and phenylbutazone in rats.
Yacobi A; Lai CM; Levy G
J Pharm Sci; 1980 Jan; 69(1):14-20. PubMed ID: 7354432
[No Abstract] [Full Text] [Related]
13. Liver disease and drug therapy.
Black M
Med Clin North Am; 1974 Sep; 58(5):1051-7. PubMed ID: 4608944
[No Abstract] [Full Text] [Related]
14. Stable isotopes in pharmacokinetic studies.
Murphy PJ; Sullivan HR
Annu Rev Pharmacol Toxicol; 1980; 20():609-21. PubMed ID: 6992706
[No Abstract] [Full Text] [Related]
15. Pharmacokinetic drug interactions with macrolide antibiotics.
Descotes J; André P; Evreux JC
J Antimicrob Chemother; 1985 Jun; 15(6):659-64. PubMed ID: 3897166
[No Abstract] [Full Text] [Related]
16. Use of limited laboratory-acquired therapeutic drug monitoring data in determining individualized drug requirements.
Bachmann KA; Forney RB; Gronau G
Ann Clin Lab Sci; 1987; 17(1):52-9. PubMed ID: 3579208
[TBL] [Abstract][Full Text] [Related]
17. A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory.
Chan KK
Drug Metab Dispos; 1982; 10(5):474-9. PubMed ID: 6183086
[TBL] [Abstract][Full Text] [Related]
18. Carbamazepine and valproic acid.
Levy RH
Res Publ Assoc Res Nerv Ment Dis; 1983; 61():171-8. PubMed ID: 6405464
[No Abstract] [Full Text] [Related]
19. Michaelis-Menten absorption kinetics in drugs: - examples and implications.
Wood JH; Thakker KM
Eur J Clin Pharmacol; 1982; 23(2):183-8. PubMed ID: 7140809
[TBL] [Abstract][Full Text] [Related]
20. Pathophysiological factors influencing drug kinetics.
Breckenridge A
Acta Pharmacol Toxicol (Copenh); 1971; 29 Suppl 3():225-32. PubMed ID: 5316404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
